Riskpilot← Back to searchSign inGet full accessTERAPIPONNI AS
ASActiveOrg 926516361Karikroken 4B, 4045 HafrsfjordOther human health activities n.e.c. · NACE 8699Est. 20210 employees
Revenue 2024
NOK 245K
-6% vs 2023
EBITDA margin
14.3%
+109% vs 2023
Equity ratio
97.9%
Financial strength
Net profit 2024
NOK 30K
+220% vs 2023
| Revenue | NOK 245K | -6% |
| EBITDA | NOK 35K | +109% |
| Net profit | NOK 30K | +220% |
| Total assets | NOK 34K | -43% |
| Equity | NOK 33K | +937% |
| Employees | 0 | — |
Legal name
TERAPIPONNI AS
Org number
926516361
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
3. februar 2021
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Gjennom helsefremmende arbeid med bruk av terapiponnier, skal selskapet bidra til å bedre menneskers fysiske og psykiske helse. Selskapet har ikke som formål å oppnå økonomisk vinning for seg selv eller sine eiere. Det skal ikke deles ut utbytte til aksjonærer. Eventuelt overskudd i selskapet skal brukes til å realisere selskapets formål. Ved likvidasjon skal eventuelt overskudd ikke utdeles til aksjonærene, men til et allmennyttig formål etter styrets nærmere beslutning.
Address
Karikroken 4B, 4045 Hafrsfjord
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 219 | 205 | 260 | 245 |
| Staff expenses | −0 | −0 | −0 | −0 |
| EBITDA | 16 | −37 | 17 | 35 |
| Depreciation & amort. | −2 | −7 | −7 | −5 |
| EBIT | 14 | −44 | 9 | 30 |
| Net financials | 0 | 0 | 0 | 0 |
| Profit before tax | 14 | −44 | 9 | 30 |
| Tax | 2 | −1 | −0 | 0 |
| Net profit | 12 | −43 | 9 | 30 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 64 | 66 | 59 | 34 |
| Equity | 37 | −6 | 3 | 33 |
| Long-term debt | 1 | 0 | 0 | 0 |
| Short-term debt | 26 | 72 | 56 | 1 |
| Total debt | 27 | 72 | 56 | 1 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
20212024
Return on equity
90.4%
This company
18.4%
Market median
+391% vs market
20212024
Net profit margin
12.2%
This company
8.1%
Market median
+51% vs market
20212024
Asset turnover
7.23×
This company
1.12×
Market median
+546% vs market
20212024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-22 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Viten & Vilje As
TERAPIPONNI AS Board members of TERAPIPONNI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrikke Lindal | Chairman | 0 companies |
| Ragny Bergesen | Chairman | 0 companies |